Author

B. Asbach

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

G. W. Carnell· 2 shared J. L. Heeney· 2 shared M. Ferrari· 2 shared N. J. Temperton· 2 shared R. Kinsley· 2 shared R. Wagner· 2 shared A. C. Banyard· 1 shared C. T. Sabeta· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

G. W. Carnell

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Influenza A (N1-N9) and Influenza B (B/Vic and B/Yam) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine design

K. A. S. da Costa, J. M. M. Del Rosario, M. Ferrari, S. Vishwanath, B. Asbach, R. Kinsley, R. Wagner, J. L. Heeney, G. W. Carnell, N. J. Temperton

The paper develops NA pseudotype vectors and a pELLA assay to measure neuraminidase inhibition, showing improved sensitivity over existing methods for vaccine immunogenicity assessment.

bioRxiv · Sep 19, 2021 · PreprintImmunology

Establishment of pan-Influenza A (H1-H18) and pan-Influenza B (pre-split, Vic/Yam) Pseudotype Libraries for efficient vaccine antigen selection

J. M. Del Rosario, K. da Costa, B. Asbach, F. Ferrara, M. Ferrari, D. Wells, G. S. Mann, V. O. Ameh, C. T. Sabeta, A. C. Banyard, R. Kinsley, S. D. Scott, R. Wagner, J. L. Heeney, G. W. Carnell, N. J. Temperton

The paper develops HA pseudotype libraries for Influenza A and B to improve vaccine antigen selection and neutralization assay capabilities.

bioRxiv · May 20, 2021 · PreprintImmunology